RYBREVANT FASPRO™ Receives FDA Approval for First-Line EGFR-Mutated NSCLC
December 26, 2025
Brand Name :
myocalm, qropi, dinagen, nootropil
Synonyms :
piracetam
Class :
Psychiatry & Neurology, Herbals
may enhance the effects by pharmacodynamic synergism when combined with cilostazol
may enhance the effects by pharmacodynamic synergism when combined with clopidogrel
may enhance the effects by pharmacodynamic synergism when combined with dipyridamole
may enhance the effects by pharmacodynamic synergism when combined with eptifibatide
may enhance the effects by pharmacodynamic synergism when combined with prasugrel
may enhance the effects by pharmacodynamic synergism when combined with ticlopidine
may enhance the effects by pharmacodynamic synergism when combined with tirofiban
Actions and Spectrum:
The spectrum of use for piracetam primarily revolves around cognitive enhancement and neuroprotection. It is often used by individuals seeking to improve their cognitive abilities, including students, professionals, and individuals experiencing age-related cognitive decline.
Frequency not defined
weight gain
insomnia
depression
rash
diarrhoea
somnolence
Nervousness
hyperkinesia
Black Box Warning
There are no known black box warnings associated with piracetam.
Contraindications:
Cautions:
Comorbidities:
Pregnancy warnings:
Pregnancy category: contraindicated
Lactation: contraindicated
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology
Pharmacodynamics
Pharmacokinetics
Absorption
piracetam is well-absorbed after oral administration. It gets rapidly and completely absorbed from the gastrointestinal tract, with peak blood levels typically reached within 1 to 3 hours. The bioavailability of piracetam is approximately 100%.
Distribution
piracetam has a low binding affinity to plasma proteins, which allows it to distribute widely throughout the body, including the brain. It readily crosses the blood-brain barrier, reaching therapeutic concentrations in the central nervous system (CNS).
Metabolism
piracetam has minimal metabolism in the body. It is excreted unchanged in the urine. The liver plays a minor role in metabolizing piracetam, with only a small fraction being metabolized through hydroxylation and glucuronidation.
Elimination and excretion
piracetam is eliminated via the kidneys. Approximately 80% of the administered dose gets excreted unchanged in the urine. Renal impairment may affect the clearance of piracetam, and dose adjustments may be necessary in individuals with severe renal impairment.
Administration:
Patient information leaflet
Generic Name: piracetam
Pronounced: (pye-RAH-seh-tam)
Why do we use piracetam?